iX Biopharma Ltd. (SGX: 42C)

iX Biopharma Balance Sheet

Financials in millions SGD. Fiscal year is July - June.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2024	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Cash & Equivalents	1.77	1.77	6.52	13.49	6.21	5.66
Short-Term Investments	0.07	0.07	0.02	0.09	0.01	0.09
Cash & Short-Term Investments	1.84	1.84	6.53	13.59	6.21	5.75
Cash Growth	-71.79%	-71.79%	-51.91%	118.65%	8.03%	-63.83%
Accounts Receivable	1.29	1.29	1.25	0.5	0.22	0.15
Other Receivables	1.63	1.63	1.8	1.48	1.59	1.15
Receivables	2.92	2.92	3.05	1.98	1.82	1.3
Inventory	1.38	1.38	0.96	0.91	1.1	0.88
Prepaid Expenses	0.44	0.44	0.44	0.37	0.22	0.21
Total Current Assets	6.59	6.59	10.98	16.84	9.35	8.14
Property, Plant & Equipment	7.61	7.61	8.22	7.72	8.95	8.29
Long-Term Investments	0.01	0.01	3.87	2.26	-	-
Goodwill	0.29	0.29	0.29	0.31	0.33	0.31
Other Intangible Assets	0	0	-	0.04	0.09	0.14
Long-Term Deferred Tax Assets	-	-	1.38	1.28	-	-
Other Long-Term Assets	0.13	0.13	0.19	0.07	0.15	0.11
Total Assets	14.62	14.62	24.93	28.52	18.86	16.98
Accounts Payable	1.26	1.26	0.4	0.22	0.55	0.85
Accrued Expenses	2.87	2.87	2.81	2.31	2.31	1.97
Current Portion of Long-Term Debt	2.49	2.49	2.75	3.29	0.42	0.22
Current Portion of Leases	0.39	0.39	0.44	0.24	0.38	0.25
Current Income Taxes Payable	0.17	0.17	0.73	1.76	-	-
Other Current Liabilities	0.21	0.21	0.05	0.04	0.02	0.02
Total Current Liabilities	7.38	7.38	7.18	7.86	3.67	3.3
Long-Term Debt	2.18	2.18	0.57	0.88	3.2	3.44
Long-Term Leases	0.14	0.14	0.58	-	0.24	0.02
Other Long-Term Liabilities	0.58	0.58	0.76	0.04	0.04	0.06
Total Liabilities	10.28	10.28	9.08	8.77	7.15	6.81
Common Stock	97.45	97.45	97.23	94.18	83.34	72.25
Retained Earnings	-96.98	-96.98	-86.18	-76.57	-71.97	-63.74
Comprensive Income & Other	3.87	3.87	4.8	2.13	0.34	1.65
Shareholders' Equity	4.34	4.34	15.85	19.74	11.71	10.17
Total Liabilities & Equity	14.62	14.62	24.93	28.52	18.86	16.98
Total Debt	5.2	5.2	4.34	4.41	4.24	3.92
Net Cash (Debt)	-3.36	-3.36	2.2	9.18	1.98	1.83
Net Cash Growth	-	-	-76.08%	363.97%	7.91%	-84.81%
Net Cash Per Share	-0.00	-0.00	0.00	0.01	0.00	0.00
Filing Date Shares Outstanding	883.34	883.34	766.3	764.9	746.17	648.89
Total Common Shares Outstanding	768.32	768.32	766.3	751.19	697.35	648.89
Working Capital	-0.8	-0.8	3.8	8.99	5.68	4.85
Book Value Per Share	0.01	0.01	0.02	0.03	0.02	0.02
Tangible Book Value	4.05	4.05	15.56	19.4	11.3	9.72
Tangible Book Value Per Share	0.01	0.01	0.02	0.03	0.02	0.01
Land	2.57	2.57	2.56	2.73	2.88	2.73
Buildings	1.74	1.74	1.74	1.85	1.97	1.85
Machinery	6.99	6.99	6.71	6.6	7.13	6.3
Leasehold Improvements	0.76	0.76	0.74	0.64	0.25	0.24

Source: S&P Capital IQ. Standard template. Financial Sources.